{"id":"https://openalex.org/W4362525148","doi":"https://doi.org/10.1158/1538-7445.am2023-1891","title":"Abstract 1891: Breaking barriers to access intracellular targets with T-cell engagers: Discovery of diverse, developable, and ultra-specific antibodies against a MAGE-A4 pMHC","display_name":"Abstract 1891: Breaking barriers to access intracellular targets with T-cell engagers: Discovery of diverse, developable, and ultra-specific antibodies against a MAGE-A4 pMHC","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362525148","doi":"https://doi.org/10.1158/1538-7445.am2023-1891"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-1891","doi":"https://doi.org/10.1158/1538-7445.am2023-1891","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-1891","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006107527","display_name":"Davide Tortora","orcid":"https://orcid.org/0000-0001-5007-3206","observed_orcids":["https://orcid.org/0000-0001-5007-3206"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Davide Tortora","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Bergqvist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Peter Bergqvist","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088831762","display_name":"Grace P. Leung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Grace P. Leung","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088473298","display_name":"Elena Vigan\u00f2","orcid":"https://orcid.org/0000-0002-5764-9113","observed_orcids":["https://orcid.org/0000-0002-5764-9113"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Elena Vigano","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070626230","display_name":"Antonios Samiotakis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Antonios Samiotakis","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056431939","display_name":"Harveer Dhupar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Harveer Dhupar","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100323732","display_name":"Wei Wei","orcid":"https://orcid.org/0000-0002-6244-3187","observed_orcids":["https://orcid.org/0000-0002-6244-3187","https://orcid.org/0000-0002-3117-9598"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Wei Wei","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075493836","display_name":"Shirley Zhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Shirley R. Zhi","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101996695","display_name":"Yukiko Sato","orcid":"https://orcid.org/0000-0003-4667-5997","observed_orcids":["https://orcid.org/0000-0003-4667-5997"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Yukiko Sato","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075985939","display_name":"Allison Goodman","orcid":"https://orcid.org/0000-0001-9833-5148","observed_orcids":["https://orcid.org/0000-0001-9833-5148"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Allison Goodman","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079539041","display_name":"Cindy-Lee Crichlow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Cindy-Lee Crichlow","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046754847","display_name":"Melissa Cid","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Melissa Cid","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060590388","display_name":"J\u00e9ssica Fernandes Scortecci","orcid":"https://orcid.org/0000-0002-9734-3477","observed_orcids":["https://orcid.org/0000-0002-9734-3477"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jessica Fernandes Scortecci","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101419793","display_name":"Ping Xiang","orcid":"https://orcid.org/0000-0003-1980-1513","observed_orcids":["https://orcid.org/0000-0003-1980-1513"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ping Xiang","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090705828","display_name":"Ahn Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ahn Lee","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101536026","display_name":"Vivian Li","orcid":"https://orcid.org/0000-0003-2971-2610","observed_orcids":["https://orcid.org/0000-0003-2971-2610"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Vivian Li","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037137679","display_name":"Stephanie K. Masterman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Stephanie Masterman","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062298376","display_name":"Sherie Duncan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sherie Duncan","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066066688","display_name":"Aaron P. Yamniuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Aaron Yamniuk","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057987399","display_name":"Kush Dalal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kush Dalal","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031485279","display_name":"Timothy M. Jacobs","orcid":"https://orcid.org/0000-0002-1062-2634","observed_orcids":["https://orcid.org/0000-0002-1062-2634"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tim Jacobs","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008160615","display_name":"Raffi Tonikian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Raffi Tonikian","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078834428","display_name":"Bryan C. Barnhart","orcid":"https://orcid.org/0000-0002-5640-1677","observed_orcids":["https://orcid.org/0000-0002-5640-1677"]},"institutions":[{"id":"https://openalex.org/I4210115631","display_name":"AbCellera (Canada)","ror":"https://ror.org/025zwvh44","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210115631"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Bryan C. Barnhart","raw_affiliation_strings":["1AbCellera Biologics Inc., Vancouver, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AbCellera Biologics Inc., Vancouver, British Columbia, Canada","institution_ids":["https://openalex.org/I4210115631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210115631"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"1891","last_page":"1891"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-engagers","display_name":"T-cell engagers","score":0.9639999866485596},{"id":"https://openalex.org/keywords/mage-a4","display_name":"MAGE-A4","score":0.9549999833106995},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.7120000123977661},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7549999952316284},{"id":"https://openalex.org/keywords/antibody-discovery","display_name":"antibody discovery","score":0.5649999976158142},{"id":"https://openalex.org/keywords/developability-assessment","display_name":"developability assessment","score":0.5130000114440918},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.7670000195503235},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5954650044441223},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.5520942807197571},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.48050081729888916},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45974451303482056},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.45233580470085144},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.43207767605781555},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42355605959892273},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.30049675703048706},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24962854385375977}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-1891","doi":"https://doi.org/10.1158/1538-7445.am2023-1891","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-1891","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388048469","https://openalex.org/W4393096401","https://openalex.org/W4282936680","https://openalex.org/W4414487927","https://openalex.org/W3107207295","https://openalex.org/W4393093578","https://openalex.org/W4287958690","https://openalex.org/W4409629640","https://openalex.org/W7148669856","https://openalex.org/W4393086532"],"abstract_inverted_index":{"Abstract":[0],"In":[1],"this":[2,32,122,165],"study,":[3],"we":[4,190,274],"describe":[5],"the":[6,21,24,38,87,135,227,322,410],"discovery":[7,108,136,150,323],"of":[8,27,91,109,125,137,144,199,252,278,294,306,316,324,396,409],"antibodies":[9,18,111,146,224,238,282,309,401],"against":[10,31,170,196,402],"a":[11,131,141,197,200,218,250,276,289,403],"MAGE-A4":[12,202,291,326,404],"peptide-major":[13],"histocompatibility":[14],"complex":[15,198,269],"(pMHC).":[16],"These":[17],"will":[19,320],"form":[20],"basis":[22],"for":[23,58,62,103,134,239,413],"tumor-binding":[25],"arm":[26],"T-cell":[28,393],"engagers":[29],"(TCEs)":[30],"target.":[33],"Bispecific":[34],"CD3":[35],"TCEs":[36,63,169,327],"have":[37,54,64,129],"potential":[39],"to":[40,48,68,73,120,167,212,222,226,288,388],"transform":[41],"cancer":[42,83],"treatment":[43],"by":[44,160,177,183],"redirecting":[45],"T":[46],"cells":[47,84,216],"tumor":[49,126,174],"targets,":[50],"but":[51,181,229],"technological":[52],"barriers":[53,387],"limited":[55,67],"their":[56],"development":[57,152],"solid":[59,179],"tumors.":[60],"Targets":[61],"generally":[65],"been":[66],"surface-expressed":[69],"proteins,":[70],"however,":[71],"access":[72,389],"intracellular":[74,93,173,390],"proteins":[75,94],"that":[76,112,154,283],"are":[77,113,118,163],"mutated":[78],"and/or":[79],"differentially":[80],"expressed":[81,176,235],"in":[82],"would":[85],"expand":[86,121],"target":[88,175],"pool.":[89],"Peptides":[90],"these":[92,307],"presented":[95,204,298],"on":[96,205,299],"MHC":[97],"class":[98,124],"I":[99],"(MHC-I)":[100],"provide":[101],"opportunities":[102],"TCE":[104],"development.":[105],"Technologies":[106],"powering":[107],"rare":[110],"ultra-specific,":[114],"high-affinity":[115],"pMHC":[116,254,405],"binders":[117],"needed":[119],"promising":[123],"targets.":[127],"We":[128,162,207,233],"developed":[130],"technology":[132,211],"platform":[133,166],"optimal":[138,329],"TCEs,":[139],"including":[140,261],"diverse":[142,193,279,314],"panel":[143,251,277,315],"CD3-binding":[145],"and":[147,151,236,242,256,266,272,280,304,313,331,399,422],"an":[148,172],"antibody":[149,194],"engine":[153],"includes":[155],"multispecific":[156],"engineering":[157],"capabilities,":[158],"powered":[159],"OrthoMabTM.":[161],"applying":[164],"develop":[168],"MAGE-A4,":[171],"many":[178],"tumors,":[180],"not":[182,230],"healthy":[184],"tissues.":[185],"Using":[186],"proprietary":[187],"immunization":[188],"technologies,":[189],"triggered":[191],"robust,":[192],"responses":[195],"human":[201,290,318],"peptide":[203,292],"MHC-I.":[206],"used":[208],"high-throughput":[209],"microfluidic":[210],"screen":[213],"single":[214],"B":[215],"using":[217,249],"multiplexed":[219],"bead-binding":[220],"assay":[221],"identify":[223],"specific":[225],"target,":[228],"closely-related":[231],"pMHCs.":[232],"then":[234],"purified":[237],"downstream":[240],"validation":[241],"characterization.":[243],"Antibody":[244],"specificity":[245],"was":[246],"initially":[247],"validated":[248],"related":[253],"complexes,":[255],"developability":[257],"properties":[258],"were":[259],"assessed,":[260],"hydrophobicity,":[262],"self-association,":[263],"polyspecificity,":[264],"stability,":[265],"aggregation.":[267],"With":[268],"data":[270],"integration":[271],"analysis,":[273],"identified":[275],"developable":[281],"bind":[284],"with":[285,310,328,392],"high":[286],"affinity":[287],"sequence":[293],"10":[295],"amino":[296],"acids":[297],"MHC-I":[300],"(HLA:02*01).":[301],"Strategic":[302],"selection":[303],"pairing":[305],"target-binding":[308],"our":[311],"large":[312],"fully":[317],"CD3-binders":[319],"power":[321],"ultra-specific":[325,400],"potency":[330],"cytokine":[332],"release.":[333],"Citation":[334],"Format:":[335],"Davide":[336],"Tortora,":[337],"Peter":[338],"Bergqvist,":[339],"Grace":[340],"P.":[341],"Leung,":[342],"Elena":[343],"Vigano,":[344],"Antonios":[345],"Samiotakis,":[346],"Harveer":[347],"Dhupar,":[348],"Wei":[349],"Wei,":[350],"Shirley":[351],"R.":[352],"Zhi,":[353],"Yukiko":[354],"Sato,":[355],"Allison":[356],"Goodman,":[357],"Cindy-Lee":[358],"Crichlow,":[359],"Melissa":[360],"Cid,":[361],"Jessica":[362],"Fernandes":[363],"Scortecci,":[364],"Ping":[365],"Xiang,":[366],"Ahn":[367],"Lee,":[368],"Vivian":[369],"Li,":[370],"Stephanie":[371],"Masterman,":[372],"Sherie":[373],"Duncan,":[374],"Aaron":[375],"Yamniuk,":[376],"Kush":[377],"Dalal,":[378],"Tim":[379],"Jacobs,":[380],"Raffi":[381],"Tonikian,":[382],"Bryan":[383],"C.":[384],"Barnhart.":[385],"Breaking":[386],"targets":[391],"engagers:":[394],"Discovery":[395],"diverse,":[397],"developable,":[398],"[abstract].":[406],"In:":[407],"Proceedings":[408],"American":[411],"Association":[412],"Cancer":[414,433],"Research":[415],"Annual":[416],"Meeting":[417],"2023;":[418],"Part":[419],"1":[420],"(Regular":[421],"Invited":[423],"Abstracts);":[424],"2023":[425],"Apr":[426],"14-19;":[427],"Orlando,":[428],"FL.":[429],"Philadelphia":[430],"(PA):":[431],"AACR;":[432],"Res":[434],"2023;83(7_Suppl):Abstract":[435],"nr":[436],"1891.":[437]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2023-04-06T00:00:00"}